Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium nitrite for prevention of vasospasm after subarachnoid hemorrhage
NCT00873015Phase 2Completed
- Sponsor
- Hope Pharmaceuticals
- Start
- Apr 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium nitrite in subarachnoid hemorrhage (SAH), sponsored by Hope Pharmaceuticals. Started Apr 2010; status: completed.
02
Drugs
sodium nitrite
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT00873015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00873015.